Covered recipient · General Payments record
DAVID PETROSIAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$672.57
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.36 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $167.63 | 6 |
| ABBVIE INC. | $163.20 | 6 |
| Lilly USA, LLC | $95.12 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.35 | 1 |
| SANOFI PASTEUR INC. | $28.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.08 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252436 | CMS |
| ABBVIE INC. | $30.32 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252440 | CMS |
| ABBVIE INC. | $23.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252445 | CMS |
| ABBVIE INC. | $27.09 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252449 | CMS |
| ABBVIE INC. | $30.51 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252453 | CMS |
| ABBVIE INC. | $24.71 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105252456 | CMS |
| GENZYME CORPORATION | $29.77 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788325 | CMS |
| GENZYME CORPORATION | $31.30 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788345 | CMS |
| GENZYME CORPORATION | $27.64 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788361 | CMS |
| GENZYME CORPORATION | $23.90 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788377 | CMS |
| GENZYME CORPORATION | $27.42 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788401 | CMS |
| GENZYME CORPORATION | $27.60 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139788415 | CMS |
| Lilly USA, LLC | $16.83 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119019 | CMS |
| Lilly USA, LLC | $27.14 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136135323 | CMS |
| Lilly USA, LLC | $25.04 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119021 | CMS |
| Lilly USA, LLC | $26.11 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127313 | CMS |
| SANOFI PASTEUR INC. | $28.06 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128745853 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.35 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152142192 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.